483
Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. – FDA 483, May 19, 2017
Record Details
An FDA inspection of Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. revealed significant deficiencies in the manufacturing of Piyanping 1% Hydrocortisone Lotion. Key issues included product mislabeling, with the lotion containing Dexamethasone instead of Hydrocortisone, and a lack of essential quality control testing. The firm also failed to maintain adequate facility hygiene, proper recall procedures, equipment qualification, and complete batch records.
- Inspection date
- May 19, 2017
- Product type
- drugs
View Company Profile
ID · 3d7362d5-e071-43f2-bf6b-fda5504bb5ee
Other documents for Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.